|
Originally published In Press as doi:10.1074/jbc.M608599200 on February 5, 2007
J. Biol. Chem., Vol. 282, Issue 15, 10846-10852, April 13, 2007
A Novel Protein-processing Domain in Gli2 and Gli3 Differentially Blocks Complete Protein Degradation by the Proteasome*
Yong Pan and
Baolin Wang 1
From the
Department of Genetic Medicine and Department of Cell and Developmental Biology, Weill Medical College of Cornell University, New York, New York 10021
The proteasome usually completely degrades its target proteins, but it can also degrade a handful of proteins in a limited and site-specific manner. The molecular mechanism for such limited degradation is unknown. The repressor forms of Gli2 and Gli3 transcription factors are generated from their full-length proteins through limited proteasome-mediated protein degradation. In this study, we have taken advantage of the fact that Gli3 is efficiently processed, whereas Gli2 is not, and identified a region of 200 residues in their C termini that determine differential processing of the two proteins. This region, named processing determinant domain, functions as a signal for protein processing in the context of not only Gli2 and Gli3 protein sequences but also a heterologous hybrid protein, which would otherwise be completely degraded by the proteasome. Thus, the processing determinant domain constitutes a novel domain that functions independently. Our findings explain, at the molecular level, why Gli2 and Gli3 are differentially processed and, more importantly, may help understand a probably general mechanism by which the proteasome degrades some of its target proteins partially rather than completely.
Received for publication, September 6, 2006
, and in revised form, January 23, 2007.
* This work was supported by National Institutes of Health Grant R01 GM70820 (to B. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Genetic Medicine, Weill Medical College of Cornell University, 1300 York Ave., W404, New York, NY 10021. Tel.: 212-746-5357; Fax: 212-746-8318; E-mail: baw2001{at}med.cornell.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Zhao, S.-Y. Ko, J.-H. Liu, D. Chen, J. Zhang, B. Wang, S. E. Harris, B. O. Oyajobi, and G. R. Mundy
Inhibition of Microtubule Assembly in Osteoblasts Stimulates Bone Morphogenetic Protein 2 Expression and Bone Formation through Transcription Factor Gli2
Mol. Cell. Biol.,
March 1, 2009;
29(5):
1291 - 1305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Daskalogianni, S. Apcher, M. M. Candeias, N. Naski, F. Calvo, and R. Fahraeus
Gly-Ala Repeats Induce Position- and Substrate-specific Regulation of 26 S Proteasome-dependent Partial Processing
J. Biol. Chem.,
October 31, 2008;
283(44):
30090 - 30100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang and M. A. Price
A Unique Protection Signal in Cubitus interruptus Prevents Its Complete Proteasomal Degradation
Mol. Cell. Biol.,
September 15, 2008;
28(18):
5555 - 5568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Eichberger, A. Kaser, C. Pixner, C. Schmid, S. Klingler, M. Winklmayr, C. Hauser-Kronberger, F. Aberger, and A.-M. Frischauf
GLI2-specific Transcriptional Activation of the Bone Morphogenetic Protein/Activin Antagonist Follistatin in Human Epidermal Cells
J. Biol. Chem.,
May 2, 2008;
283(18):
12426 - 12437.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|